FDA NDC Directory · JSON-LD · Markdown
NDC 54123-907 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING
| Generic name | buprenorphine hydrochloride and naloxone hydrochloride |
|---|---|
| Labeler / Manufacturer | Orexo US, Inc. |
| Marketing category | New Drug Application (innovator) · App NDA204242 |
| Dosage form / route | TABLET, ORALLY DISINTEGRATING · SUBLINGUAL |
| Active ingredients | BUPRENORPHINE HYDROCHLORIDE (.7 mg/1) NALOXONE HYDROCHLORIDE (.18 mg/1) |
| Marketing started | 20130704 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).